236 related articles for article (PubMed ID: 16267727)
1. Invasive Saccharomyces infection: a comprehensive review.
Enache-Angoulvant A; Hennequin C
Clin Infect Dis; 2005 Dec; 41(11):1559-68. PubMed ID: 16267727
[TBL] [Abstract][Full Text] [Related]
2. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
3. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
4. Invasive infections due to Saccharomyces boulardii (Ultra-levure).
Prescrire Int; 2007 Jun; 16(89):110. PubMed ID: 17582930
[TBL] [Abstract][Full Text] [Related]
5. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
Imre A; Rácz HV; Antunovics Z; Rádai Z; Kovács R; Lopandic K; Pócsi I; Pfliegler WP
Microbiol Res; 2019 Oct; 227():126298. PubMed ID: 31421716
[TBL] [Abstract][Full Text] [Related]
6. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
McCullough MJ; Clemons KV; McCusker JH; Stevens DA
J Clin Microbiol; 1998 Sep; 36(9):2613-7. PubMed ID: 9705402
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces cerevisiae fungemia: an emerging infectious disease.
Muñoz P; Bouza E; Cuenca-Estrella M; Eiros JM; Pérez MJ; Sánchez-Somolinos M; Rincón C; Hortal J; Peláez T
Clin Infect Dis; 2005 Jun; 40(11):1625-34. PubMed ID: 15889360
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization.
Manzoni P; Farina D; Leonessa M; d'Oulx EA; Galletto P; Mostert M; Miniero R; Gomirato G
Pediatrics; 2006 Dec; 118(6):2359-64. PubMed ID: 17142519
[TBL] [Abstract][Full Text] [Related]
9. Invasive infection with Saccharomyces cerevisiae: report of three cases and review.
Aucott JN; Fayen J; Grossnicklas H; Morrissey A; Lederman MM; Salata RA
Rev Infect Dis; 1990; 12(3):406-11. PubMed ID: 2193348
[TBL] [Abstract][Full Text] [Related]
10. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections.
de Llanos R; Querol A; Pemán J; Gobernado M; Fernández-Espinar MT
Int J Food Microbiol; 2006 Aug; 110(3):286-90. PubMed ID: 16782223
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
12. A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors.
de Llanos R; Fernández-Espinar MT; Querol A
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):221-31. PubMed ID: 16871421
[TBL] [Abstract][Full Text] [Related]
13. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
14. Diarrhea, and the experimental treatment Saccharomyces boulardii.
James JS
AIDS Treat News; 1995 Jun; (no 224):1-4. PubMed ID: 11362510
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infection in Ramathibodi Hospital: a ten-year autopsy review.
Larbcharoensub N; Srisuma S; Ngernprasertsri T; Aroonroch R; Chongtrakool P; Santanirand P; Chirachariyavej T; Sirikulchayanonta V
J Med Assoc Thai; 2007 Dec; 90(12):2630-7. PubMed ID: 18386713
[TBL] [Abstract][Full Text] [Related]
16. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
Szajewska H; Skórka A; Dylag M
Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
[TBL] [Abstract][Full Text] [Related]
18. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
van der Aa Kühle A; Skovgaard K; Jespersen L
Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
[TBL] [Abstract][Full Text] [Related]
19. Increasing fungal infections in the intensive care unit.
De Pauw BE
Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
